ter Wengel PV, et al. The impact of early (24h) surgical decompression on neurological recovery in thoracic spinal cord injury: a meta-analysis. J Neurotrauma 2019; 36(18): 2609-17.
Babiarz JE, Blelloch R. Small RNAs–their biogenesis, regulation and function in embryonic stem cells NISEB Journal 2019; 12(4)
Ehninger A. Genetic modified pluri-or multipotent stem cells and uses thereof Google Patents. 2019.
Medvedev SP, Shevchenko AI, Zakian SM. Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine Acta naturae 2010; 2(2): 18-28.
Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors cell 2007; 131(5): 861-72.
Yue JK, Tsolinas RE, Burke JF, et al. Vasopressor support in managing acute spinal cord injury: current knowledge. J Neurosurg Sci 2019; 63(3): 308-17.
Satyavathi M, Keerthi K, Amulya K, Susmitha G, Sankar PR, Babu PS. Novel challenges of stem cell therapy in neurodegenerative disorders. Indian J Res Pharm Biotechnol 2018; 6(2): 54-8.
Wirth III ED, Lebkowski JS. Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury. Google Patents 2019.
Marton RM, Miura Y, Sloan SA, et al. Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures. Nat Neurosci 2019; 22(3): 484-91.
Ramotowski C, Qu X, Villa‐Diaz LG. Progress in the use of induced pluripotent stem cell-derived neural cells for traumatic spinal cord injuries in animal populations. Meta-Analysis and Review Stem Cells Transl Med 2019; 8(7): 681-93.
Fan L, et al. Directing induced pluripotent stem cell derived neural stem cell fate with a three-dimensional biomimetic hydrogel for spinal cord injury repair 2018; 10(21): 17742-55.